Advanced Therapies Europe

We are excited to announce our sponsorship of Phacilitate's Advanced Therapy Europe on the 5th-7th of September in Lisbon!

ATE23 Logo

Advanced Therapies Europe is dedicated to creating change through education and collaboration, offering advanced therapies professionals currently working in Europe, as well as those looking to enter the European market, the platform to meet and partner with fellow pioneers.

You can see Cell and Gene Therapy Catapult across the event at the following panels:

Title: Opening Panel with Q&A – Cultivating A Voice Of Change: Me, Myself and I

Time: 14:30, 05 Sep 2023

Speaking: Fernanda Masri, Head Of Manufacturing Innovation BD, CGT Catapult

Title: Roundtable Session One: Breaking Down Barriers: Creating Advanced Thinking Within Advanced Therapies

Time: 15:35, 05 Sep 2023

Speaking: Jacqueline Barry, Chief Clinical Officer

Title: The Genesis and Implementation of Labeling Standards to Ensure Patient Safety for CGT Therapies

Time: 14:00, 06 Sep 2023

14:20pm Presentation: Implementation of ISBT 128 labels for Cell Therapy products in a Healthcare setting.

  • Discussion of the barriers and benefits to implementing the ISBT 128 label for cellular materials as starting materials for Advanced Therapy Medicinal Products manufacture

Speaking: Jacqueline Barry, Chief Clinical Officer

Title: Critical Patient Considerations: Patient Operations That Ensure Patient Safety Throughout Cell and Gene Therapy Deployment

Time: 16:00, 06 Sep 2023

16:35pm Closing panel with Q&A

Speaking: Jacqueline Barry, Chief Clinical Officer

Joined by all session participants, and Lynette Okello, Vice President Patient Supply Operations, Achilles Therapeutics and Beth Gardner, Senior Director, Patient Supply, Beam Therapeutics

Title: Lunchtime Briefing: Practical considerations for establishing flexible, scalable manufacturing

Time: 12:15, 07 Sep 2023

Moderated by: Fernanda Masri, Head Of Manufacturing Innovation BD, CGT Catapult

Joined by Katey Adcock, Director of Operations, Stevenage Manufacturing Innovation Centre, CGT Catapult, Marc Davies, Vice President of R&D, Leucid Bio and Daniella Kranjac, Founder, Dynamk Capital

Click here to see the full agenda

If you would like to schedule a meeting with a team member, please contact us at